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Abstract
Background: Early arterial recanalisation with stent retrievers (SR) has been recently demonstrated to improve clinical
outcome of patients with large-vessel occlusion of the anterior circulation. However, the benefit of SR thrombectomy in the
setting of acute basilar artery occlusion (BAO) has not been proven yet. This study evaluated a series of consecutive patients
with BAO treated with SR, focusing on the efficacy, safety and clinical results.
Methods: We analysed 24 consecutive patients with acute BAO who were treated with SR mechanical thrombectomy. Good
clinical outcome at three months was defined as mRS 2. Data from patients with good outcome were compared to that
from patients with poor outcome.
Results: Sufficient recanalisation (TICI 2 b or 3) was achieved in 63% (15/24) of patients. At three months, 33% (8/24) of
patients had died; good clinical outcome was obtained in 21% (5/24). Age (46 vs. 60 years old, p¼ 0.05) and time from
symptoms onset to recanalisation (370 vs. 521 minutes, p¼ 0.048) was significantly lower in patients with good outcome as
compared to patients with poor outcome. There were three cases (12.5%) of periprocedural complications, all of them
related to arterial wall dissection/perforation.
Conclusions: SR thrombectomy might be an efficient and safe treatment for patients with acute BAO occlusion and might
help improve outcome.
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Introduction
Acute basilar artery occlusion (BAO) is a devastating
subtype of stroke, with high rates of morbidity and
mortality.1 Early administration of intravenous tissue
plaminogen activator (iv tPA) is still the ﬁrst-line treat-
ment modality;2 however, its results are hampered by
low recanalisation rates.3,4
Recently, mechanical thrombectomy techniques
have proved their value in strokes caused by large-
vessel occlusion of the anterior circulation. Several stu-
dies have demonstrated that early recanalization with
stent retrievers (SRs) improves functional outcome as
compared to iv tPA alone.5–9 Regarding BAO, small
series have suggested that thrombectomy with SRs
might also contribute towards a better outcome. A
recent meta-analysis and a large prospective German
and Austrian registry provided further support for
this hypothesis.10,11 Despite these promising results,
the real beneﬁt of SR thrombectomy for acute BAO
has not been proven yet.
The aim of this study was to analyse our ser-
ies of consecutive patients with BAO treated with SRs,
focusing on the eﬃcacy, safety and clinical results.
Materials and methods
Patients
Since 2012, data from all patients with acute ischaemic
stroke treated with mechanical thrombectomy at our
institution have been collected in a prospectively main-
tained database. From 2012 to 2014, 97 patients with
large-vessel occlusion were treated with mechanical
thrombectomy with the use of SRs. Among these, we
collected data (clinical and angiographic) from all
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24 patients who presented with acute BAO. The insti-
tutional ethics committee approved this analysis.
Patients were either admitted directly to our insti-
tution or secondarily referred from other hospitals.
On admission, all patients were evaluated by a
neurologist and their neurological condition was
quantiﬁed using the National Institutes of Health
Stroke Scale International (NIHSS). Imaging evalu-
ation consisted of non-enhanced computed tomog-
raphy (CT) and CT angiography (from the aortic
arch to the vertex). The decision to undergo mechan-
ical thrombectomy was made in agreement by the
neurologist and the interventional neuroradiologist.
The main inclusion criteria for thrombectomy were
the following: baseline NIHSS 10; BAO conﬁrmed
with CT angiography; exclusion of intracranial haem-
orrhage; exclusion of ‘extensive established brainstem
infarction’ as evaluated by the neuroradiologist (no
posterior circulation Alberta Stroke Program Early
CT Score (pc-ASPECTS) was used). Whenever
patients arrived at the hospital within 4.5 h of symp-
tom onset (and there were no contraindications) full-
dose (0.9mg/kg) iv-tPA was administered as bridging
therapy.
Endovascular treatment
All procedures were performed by an interventional
neuroradiologist with at least two years of experience.
Informed consent was obtained from relatives when-
ever possible; for the remainder, consent was presumed.
All patients were treated under general anaesthesia. The
most typical setup was as follows: A 6F sheath was
introduced in the right femoral artery and a guide-
catheter (usually a 6F) was navigated to the V2 seg-
ment of the dominant vertebral artery, as high as safely
possible. A diagnostic angiogram was performed to
conﬁrm the occlusion and to assess collateral circula-
tion. Afterward, under roadmap, a 0.021-inch micro-
catheter and a 0.014-inch guidewire were used to
cross the clot and a super-selective angiogram was per-
formed to conﬁrm a safe distal position. A 4 20mm
retrievable stent was then advanced and deployed
across the occluded segment; Trevo Provue was used
in 21 patients and Solitaire FR in three patients. The
SR was left in place for 5 minutes, after which both the
microcatheter and the SR were retrieved under manual
aspiration at the guide catheter. If recanalisation was
not successful, further attempts were performed.
Whenever there was suspicion of an underlying high-
grade stenosis, balloon angioplasty intracranial stent
(Wingspan) was considered. In cases of stent deploy-
ment, patients were loaded with abciximab (intra-
arterial (ia)þ iv) and, after 12 h, double antiplatelet
therapy with aspirin and clopidogrel was administered.
All patients were admitted to a dedicated stroke unit.
Control CT was performed in all cases 24 h after the
procedure. After three months, all patients were seen by
a neurologist.
Outcome measurements
We analysed age, gender, baseline NIHSS score, iv tPA
administration, recanalisation, time from symptoms
onset to recanalisation, use of angioplasty stenting,
periprocedural complications and clinical outcome.
Recanalisation status was assessed according to the
Thrombolysis in Cerebral Infarction (TICI) scale.12
TICI 2 b and 3 were rated as suﬃcient recanalisation;
TICI 2 a was rated as insuﬃcient. Clinical outcome
three months after the procedure was quantiﬁed using
the modiﬁed Rankin scale (mRS); good outcome was
deﬁned as an mRS 2.
Statistical analysis
A bivariate analysis was undertaken to determine the
relationship between clinical outcome and some of the
other variables. Mann-Whitney U test was used for
continuous variables and Fisher’s exact test for cat-
egoric variables. A value of p< 0.05 was considered
signiﬁcant. All statistical analyses were performed
with SPSS (version 19.0; IBM, Armonk, NY, USA).
Results
During the study period there were 24 patients with
acute BAO. Table 1 shows baseline patient character-
istics according to clinical outcome.
Most patients were male (71%) and their mean age
was 57 (range, 27–80 years old). Median NIHSS score
at presentation was 20 and ranged from 12 to 36. It
should be noted, however, that at arrival at our hospital
many patients were already sedated and ventilated to
allow for inter-hospital transfer. Iv tPA was adminis-
tered to 11 (46%) patients prior to the endovascular
procedure.
After the use of SR alone, suﬃcient recanalisation
(TICI 2b and 3) was achieved in 54% of patients. In
two cases, additional recanalization manoeuvres were
adopted: In one patient, simple balloon angioplasty
was performed; in the other patient, balloon angio-
plasty failed to reopen the artery and a stent was
Table 1. Baseline characteristics of the study population.
Good
outcome
(n¼ 5)
Bad
outcome
(n¼ 19)
Total
(n¼ 24) P
Age, y (mean SD) 46 19 60 10 57 14 .05
Sex, male, n (%) 3 (60%) 14 (74%) 17 (71%) NS
Baseline NIHSS 21 9 23 8 23 8 NS
ivtPA 3 (60%) 8 (42%) 11 (46%) NS
Sufficient recanalization 4 (80%) 11(58%) 15 (63%) NS
Time to
recanalization, min
370 66 521 145 480 144 .048
NS: non-significant.
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deployed (as described above). In both cases, ﬁnal reca-
nalisation status was improved. Combining the results
of all procedures, suﬃcient recanalisation was achieved
in 63% of patients. On average, recanalisation was
achieved only 8 h after symptoms onset (ranging from
5 to 12 h).
According to the European Cooperative Acute
Stroke Study (ECASS) criteria,13 there was only one
case of haemorrhagic transformation, in which petech-
ial infarction without space-occupying eﬀect occurred
(haemorrhagic infarction (HI) 1); there were no cases of
parenchymal haematomas.
Regarding periprocedural complications, there were
three cases of arterial dissection or perforation, all of
them involving a lesion of the right posterior cerebral
artery caused by microwire and microcatheter manipu-
lation (i.e. unrelated to the SR itself). All patients had
received iv tPA prior to the endovascular treatment. In
one case the consequences were minimal and the patient
evolved with good clinical outcome at three months;
however, in the remaining cases the associated sub-
arachnoid haemorrhage was severe and the patients
subsequently died (for both cases the cause of death
was attributed both to unresolved BAO and to haem-
orrhage). One of these cases is illustrated in Figure 1.
At three months, eight patients (33%) had died;
most of them died during the ﬁrst week after the
stroke. Only ﬁve patients (21%) had an mRS score 2;
there were also ﬁve patients with a score of 3.
In bivariate analysis, patients with good outcome
were signiﬁcantly younger (46 vs. 60 years old) and
recanalised earlier (370 vs. 521 minutes) as compared
to those with poor outcome. Gender, NIHSS score at
presentation and prior administration of iv tPA were
not found to be related to clinical outcome. Despite the
fact that recanalisation results were better (80% vs.
58% of suﬃcient recanalisation) for the group with
good clinical outcome, this variable failed to show stat-
istical signiﬁcance.
Discussion
This single-centre retrospective study analyses the use
of thrombectomy with SRs in acute BAO.
The beneﬁt of thrombectomy for cases of acute BAO
has not been proven in a randomised clinical trial yet.
There are, however, a few case series suggesting that, in
the setting of acute BAO, thrombectomy is feasible,
eﬃcient, safe and may improve clinical outcome. The
largest observational study so far published in this ﬁeld
was the International Multicenter Registry for
Mechanical Recanalization Procedures in Acute
Stroke (ENDOSTROKE),11 which included 148 con-
secutive patients. In this study, TICI 2b or 3 was
achieved in 79% of patients; three-month mortality
rate was 35% and the percentage of patients with
mRS 2 was 34%. Recently, Gory et al.10 performed
a meta-analysis of 15 previously published studies (case
series) and included their own data, involving a total of
312 individuals. The estimated recanalisation rate
reached 81%, three-month mortality was 30% and a
favourable outcome was achieved in 42%.
In our series, recanalisation rate was 63%, between
16% and 18% inferior as compared to the rates pub-
lished in the two largest studies mentioned above.10,11
This might be explained, on the one hand, by the con-
servative approach our team adopts. All thrombec-
tomies were performed with SRs (aspiration
techniques were not available) and only one device
was used in each patient; the average number of
Figure 1. Left: Left vertebral artery injection through the guide catheter demonstrated complete occlusion of the basilar artery. Centre:
The microcatheter and the microwire were navigated to the P1 segment of the right posterior cerebral artery; however, selective injection
through the microcatheter showed contrast extravasation due to perforation/dissection of the arterial wall. Right: As a consequence, an
important subarachnoid haemorrhage developed, with hydrocephalus.
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passages was 2.2 and the maximum was ﬁve. Using a
second device (either subsequently or simultaneously)
or changing to a diﬀerent thrombectomy technique
(like primary aspiration or the A Direct Aspiration,
First Pass Technique (ADAPT) technique) might help
solve some cases of refractory arterial occlusions.14–16
On the other hand, our moderate number of thromb-
ectomy cases per year might also have contributed to
these results. By comparing the recanalization rates
among recently published trials of thrombectomy for
anterior circulation strokes,5–9 it is possible to notice
that lower-volume centres (as those involved in the
Multicenter Randomized Clinical Trial of
Endovascular Treatment for Acute Ischemic Stroke in
the Netherlands (MR CLEAN) trial) have lower reca-
nalisation rates as compared to higher-volume centres.
The three-month mortality in this series was 33%, in
line with the most recent studies.10,11 Acute BAO car-
ries a very poor outcome and has the highest mortality
rate among large-vessel occlusions.1,17 For anterior cir-
culation strokes, a recent meta-analysis demonstrated
that thrombectomy reduces the risk of mortality (as
compared to iv tPA);18 hence, it might have a similar
eﬀect in acute BAO.
At 90 days, the proportion of patients in this series
who had an mRS 2 was 21% (5/24). However, since
acute BAO is such a hazardous condition, some authors
have considered an mRS of 3 as a moderate result11 and
a signiﬁcant improvement as compared to the natural
history. If we had adopted such a classiﬁcation, the
proportion of patients with good and moderate
outcome (mRS 3) would have been 42% (10/24).
We had three periprocedural complications (12.5%),
all of them consisting of inadvertent perforation or dis-
section of the right posterior cerebral artery. We believe
that most were due to microwire penetration inside the
small thalamoperforating arteries, as illustrated in a
recent paper by Eom et al.19 As a consequence, most
recently we have tried to keep the microwire proximal
to the clot, using only the microcatheter to cross it.
We found that age and time from symptoms onset to
recanalisation were associated with clinical outcome.
The association between older age and poorer out-
comes for patients with acute BAO treated with
thrombectomy has been (retrospectively) reported by
some other authors.10,11,20 Moreover, an index (SPAN
index) combining age and NIHSS score has been sug-
gested as an independent predictor of outcome both for
patients treated with iv tPA and for patients treated
with thrombectomy.21,22 The importance of faster reca-
nalisation cannot be overemphasised. Two recent inde-
pendent analyses demonstrated that, for anterior
circulation strokes, onset-to-reperfusion time aﬀects
both mortality and outcome and should be kept in
mind as the main target in acute stroke patient man-
agement.23,24 Most likely, this also applies to acute
BAO. However, since the pathophysiology of the anter-
ior and posterior circulation infarctions might not be
the same, one should be aware that the temporal
evolution might also diﬀer between these two terri-
tories.25,26 This diﬀerent pathophysiology might also
explain why, in this series of acute BAO, recanalisation
was not found to be related to good clinical outcome,
unlike anterior circulation strokes, in which recanalisa-
tion has been repeatedly shown to improve the
outcome.
Others have found diﬀerent factors aﬀecting the out-
come of patients with acute BAO treated with SRs.
Blood pressure,11,27 blood sugar levels,28 severity of
symptoms at presentation,11,27,28 thrombus localisa-
tion,10 volume of the established infarction prior to
treatment,20,29 collateral circulation11,28 and recanalisa-
tion status29 have all been suggested to inﬂuence the
ﬁnal outcome in this group of patients.
The main limitations of this study are its small popu-
lation, its retrospective nature and its single-centre
analysis.
Conclusions
Our results suggest that thrombectomy with the use of
SRs might be an eﬃcient and safe treatment for
patients with acute BAO occlusion and might help
improve outcome; however, even in the era of SRs,
acute BAO is still a devastating condition. Moreover,
age and time from symptoms onset to recanalisation
have an inﬂuence on ﬁnal outcome. Finally, arterial
dissection or perforation is one of the main complica-
tions of this treatment.
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